These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 8572899)
21. [Pretreatment of donor dendritic cells with NBD-peptide prolongs mouse cardiac allograft survival]. Su G; Zhao WZ; Chen JJ; Xu J; Qiao CH; Liu C; Sun ZQ Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(9):1562-7. PubMed ID: 18819868 [TBL] [Abstract][Full Text] [Related]
22. Prolonged heart allograft survival resulted from donor-specific T-cell sequestering and removal by selective splenectomy in mice. Zhu XH; Chen S; Chen ZK Transplant Proc; 2004 Oct; 36(8):2448-9. PubMed ID: 15561276 [TBL] [Abstract][Full Text] [Related]
23. Influence of a transfusion of donor leukocytes treated with 8-methoxypsoralen and long-wave ultraviolet light (PUVA) on skin allograft survival in mice. Gruner S; Noack F; Meffert H Biomed Biochim Acta; 1989; 48(7):477-85. PubMed ID: 2803285 [TBL] [Abstract][Full Text] [Related]
24. Prolongation of survival of fully allogeneic cardiac grafts and generation of regulatory cells by a histamine receptor 2 antagonist. Inoue F; Zhang Q; Akiyoshi T; Aramaki O; Iwami D; Matsumoto K; Kitagawa Y; Shirasugi N; Niimi M Transplantation; 2007 Nov; 84(10):1288-97. PubMed ID: 18049114 [TBL] [Abstract][Full Text] [Related]
25. Role of CXCR3 and CCR5 in allograft rejection. Schnickel GT; Hsieh GR; Garcia C; Shefizadeh A; Fishbein MC; Ardehali A Transplant Proc; 2006 Dec; 38(10):3221-4. PubMed ID: 17175228 [TBL] [Abstract][Full Text] [Related]
26. Pretransplant blood transfusion with cyclophosphamide: efficacious means of prolonging allograft survival. Lagodzinski Z; Gorski A Folia Biol (Praha); 1991; 37(1):21-6. PubMed ID: 2070885 [TBL] [Abstract][Full Text] [Related]
27. The immunoregulatory roles of natural killer T cells in cyclophosphamide-induced tolerance. Iwai T; Tomita Y; Shimizu I; Kajiwara T; Onzuka T; Okano S; Yasunami Y; Yoshikai Y; Nomoto K; Tominaga R Transplantation; 2007 Dec; 84(12):1686-95. PubMed ID: 18165782 [TBL] [Abstract][Full Text] [Related]
29. Specific immunosuppression of corneal allograft rejection by combination of anti-VLA-4 and anti-LFA-1 monoclonal antibodies in mice. Hori J; Isobe M; Yamagami S; Mizuochi T; Tsuru T Exp Eye Res; 1997 Jul; 65(1):89-98. PubMed ID: 9237869 [TBL] [Abstract][Full Text] [Related]
30. Attenuation of acute xenograft rejection by short-term treatment with LF15-0195 and monoclonal antibody against CD45RB in a rat-to-mouse cardiac transplantation model. Wang H; Hosiawa KA; Garcia B; Shum JB; Dutartre P; Kelvin DJ; Zhong R Transplantation; 2003 May; 75(9):1475-81. PubMed ID: 12792500 [TBL] [Abstract][Full Text] [Related]
31. Cardiac graft rejection in hypersensitized recipients: prevention of antibody response and graft rejection using brequinar sodium. Yasunaga C; Cramer DV; Chapman FA; Wang HK; Barnett M; Wu GD; Makowka L Transplant Proc; 1993 Jun; 25(3 Suppl 2):65-6. PubMed ID: 8516948 [No Abstract] [Full Text] [Related]
32. Donor bone marrow cells play a role in the prevention of accelerated graft rejection induced by semi-allogeneic spleen cells in transplantation. de Moraes LV; Bueno V; Marguti I; Martins GA; Vallochi AL; Yamamoto GL; Panajotopoulos N; Mengel JO; Rizzo LV Transpl Immunol; 2008 Feb; 18(4):330-7. PubMed ID: 18158119 [TBL] [Abstract][Full Text] [Related]
33. Suppression of acute and chronic cardiac allograft rejection in mice by inhibition of chemokine receptor 5 in combination with cyclosporine A. Li J; Xia J; Zhang K; Xu L J Surg Res; 2009 Nov; 157(1):81-90. PubMed ID: 19577762 [TBL] [Abstract][Full Text] [Related]
34. The specific monocarboxylate transporter (MCT1) inhibitor, AR-C117977, a novel immunosuppressant, prolongs allograft survival in the mouse. Bueno V; Binet I; Steger U; Bundick R; Ferguson D; Murray C; Donald D; Wood K Transplantation; 2007 Nov; 84(9):1204-7. PubMed ID: 17998878 [TBL] [Abstract][Full Text] [Related]
35. Intravenous pulse administration of cyclophosphamide is an effective and safe treatment for sensitized cardiac allograft recipients. Itescu S; Burke E; Lietz K; John R; Mancini D; Michler R; Rose E; Oz M; Edwards N Circulation; 2002 Mar; 105(10):1214-9. PubMed ID: 11889016 [TBL] [Abstract][Full Text] [Related]